Amelioration of Alzheimer's disease by neuroprotective effect of sulforaphane in animal model.
about
Sulforaphane as a potential protective phytochemical against neurodegenerative diseasesEPPS rescues hippocampus-dependent cognitive deficits in APP/PS1 mice by disaggregation of amyloid-β oligomers and plaquesAdaptive cellular stress pathways as therapeutic targets of dietary phytochemicals: focus on the nervous systemConditional Knockout of Cav2.1 Disrupts the Accuracy of Spatial Recognition of CA1 Place Cells and Spatial/Contextual Recognition Behavior.Neuroprotective effects of sulforaphane on cholinergic neurons in mice with Alzheimer's disease-like lesions.Redox-based therapeutics in neurodegenerative disease.Direct Keap1-Nrf2 disruption as a potential therapeutic target for Alzheimer's disease.Pyrrolidine dithiocarbamate activates the Nrf2 pathway in astrocytes.Nrf2--a therapeutic target for the treatment of neurodegenerative diseases.Attenuation of β-amyloid-induced oxidative cell death by sulforaphane via activation of NF-E2-related factor 2.Nec-1 alleviates cognitive impairment with reduction of Aβ and tau abnormalities in APP/PS1 mice.Sulforaphane enhances proteasomal and autophagic activities in mice and is a potential therapeutic reagent for Huntington's disease.Melatonin as a versatile molecule to design novel multitarget hybrids against neurodegeneration.Epigallocatechin-3-gallate enhances clearance of phosphorylated tau in primary neurons.Alantolactone and Isoalantolactone Prevent Amyloid β25-35 -induced Toxicity in Mouse Cortical Neurons and Scopolamine-induced Cognitive Impairment in Mice.The role of modulation of antioxidant enzyme systems in the treatment of neurodegenerative diseases.Nrf2-a Promising Therapeutic Target for Defensing Against Oxidative Stress in Stroke.Sulforaphane induces autophagy through ERK activation in neuronal cells.Pharmacological therapeutics in Friedreich ataxia: the present state.Are Astrocytes the Predominant Cell Type for Activation of Nrf2 in Aging and Neurodegeneration?Melatonin-sulforaphane hybrid ITH12674 induces neuroprotection in oxidative stress conditions by a 'drug-prodrug' mechanism of actionSulforaphane epigenetically enhances neuronal BDNF expression and TrkB signaling pathways.Taurine-Carbohydrate Derivative Stimulates Fibrillogenesis of Amyloid-β and Reduce Alzheimer-Like Behaviors.Soybean-Derived Phytoalexins Improve Cognitive Function through Activation of Nrf2/HO-1 Signaling Pathway.Sulforaphane ameliorates neurobehavioral deficits and protects the brain from amyloid β deposits and peroxidation in mice with Alzheimer-like lesions.Cognition Enhancing Activity of Sulforaphane Against Scopolamine Induced Cognitive Impairment in Zebra Fish (Danio rerio).Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits.Sulforaphane rescues amyloid-β peptide-mediated decrease in MerTK expression through its anti-inflammatory effect in human THP-1 macrophages.Sulforaphane Protects against Brain Diseases: Roles of Cytoprotective Enzymes.Protective Effect of Glucosinolates Hydrolytic Products in Neurodegenerative Diseases (NDDs).Protective Effects of 6-(Methylsulfinyl)hexyl Isothiocyanate on Aβ-Induced Cognitive Deficit, Oxidative Stress, Inflammation, and Apoptosis in MiceDysfunction of Nrf2-ARE Signaling Pathway: Potential Pathogenesis in the Development of Neurocognitive Impairment in Patients with Moderate to Severe Obstructive Sleep Apnea-Hypopnea Syndrome
P2860
Q21285068-11B7FDB5-7EA2-4C4E-9B16-91898D6FF0F9Q27316634-E2AB8B56-A5B3-470F-8182-A05A36F1AF20Q28389419-4739AE36-9716-499F-9CBA-5827BCE233FAQ30827251-1B08496C-B31F-4024-B073-6E68AE2D5544Q34158616-46A08323-5C52-4393-A4AB-B2D24D04EB21Q34535918-9262E99D-FC07-4825-B409-C58C0399F390Q36295178-5E1A6425-B6E5-40CB-8C0F-7CA1E44050E6Q36622182-D781A819-C0B5-44A2-875B-41C8E6857056Q36732766-35BE7A4E-C32B-48D2-9FFB-BBB6BA709583Q36995865-646225AF-D5D3-4B47-89BC-6388208BE892Q37555484-C902F571-8BBF-404D-9C87-16CB982A5DDFQ37719851-BE4D1A11-FE00-4B08-A538-8ADCB3566863Q38684594-9115ECF7-AC93-414B-BCF4-1A4D41623D22Q38849708-EDD4E6E6-8C9B-47D2-B38E-975A31922ACFQ38888174-131E689C-E7AA-4F3B-8DD4-3578BA885693Q38889475-C1DFAE64-E760-4389-B39E-5E2B29EB2EA7Q38970553-9243AA90-65EC-48FA-BE24-DA35C00972CCQ38982423-66F2AE34-97EE-45F5-B0D9-A2EB5A88051DQ39445743-78D5C06E-D8EC-4CAE-B4A5-7CB95F33FFB3Q41662736-C4B8B0C7-AE7A-45B2-A269-398DD869A307Q42107527-0278263E-753C-40F5-8CB6-03C3FA40B7B4Q43650001-79E713A6-1B9C-4BFB-88A8-1000BB6919F1Q47744679-48C889BD-BE3A-48AD-8F12-699328CD40BFQ48235702-6FBD3059-30BF-4B23-BA0D-D63F65F4B26AQ48659626-21E947B7-2174-4817-926C-6BF864B2C05AQ50507255-26FC762C-9E13-40AD-B308-79DEE06F8874Q51409146-E30C3A15-BA53-488B-8781-7F28B7A71168Q53079574-2D87DB22-059A-4DA0-9FAD-E2ECE5FA3B92Q55060241-901F37BB-A1E5-49CA-9EDD-8F99FC92B589Q55283127-3098A06A-CD56-473C-A589-6711468AFCBBQ56364791-62F19BAF-A6C6-44DA-B365-5C00720E47ACQ58787803-0C09D90C-F490-4CE9-A5D4-C44987B3200D
P2860
Amelioration of Alzheimer's disease by neuroprotective effect of sulforaphane in animal model.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Amelioration of Alzheimer's di ...... sulforaphane in animal model.
@en
Amelioration of Alzheimer's di ...... sulforaphane in animal model.
@nl
type
label
Amelioration of Alzheimer's di ...... sulforaphane in animal model.
@en
Amelioration of Alzheimer's di ...... sulforaphane in animal model.
@nl
prefLabel
Amelioration of Alzheimer's di ...... sulforaphane in animal model.
@en
Amelioration of Alzheimer's di ...... sulforaphane in animal model.
@nl
P2093
P2860
P1433
P1476
Amelioration of Alzheimer's di ...... sulforaphane in animal model.
@en
P2093
Dong Jin Kim
Hanna Y Ehrlich
Hye Yun Kim
Hyunjin Vincent Kim
Seon Young Choi
YoungSoo Kim
P2860
P356
10.3109/13506129.2012.751367
P577
2012-12-19T00:00:00Z